These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22772553)

  • 1. Primed for inflammation: enthesis-resident T cells.
    Lories RJ; McInnes IB
    Nat Med; 2012 Jul; 18(7):1018-9. PubMed ID: 22772553
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.
    Sherlock JP; Joyce-Shaikh B; Turner SP; Chao CC; Sathe M; Grein J; Gorman DM; Bowman EP; McClanahan TK; Yearley JH; Eberl G; Buckley CD; Kastelein RA; Pierce RH; Laface DM; Cua DJ
    Nat Med; 2012 Jul; 18(7):1069-76. PubMed ID: 22772566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-23-Dependent γ/δ T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice.
    Reinhardt A; Yevsa T; Worbs T; Lienenklaus S; Sandrock I; Oberdörfer L; Korn T; Weiss S; Förster R; Prinz I
    Arthritis Rheumatol; 2016 Oct; 68(10):2476-86. PubMed ID: 27111864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spreading spondyloarthritis: are ILCs cytokine shuttles from base camp gut?
    Neerinckx B; Elewaut D; Lories RJ
    Ann Rheum Dis; 2015 Sep; 74(9):1633-5. PubMed ID: 26199396
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy.
    Bridgewood C; Sharif K; Sherlock J; Watad A; McGonagle D
    Immunol Rev; 2020 Mar; 294(1):27-47. PubMed ID: 31957051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.
    Kehl AS; Corr M; Weisman MH
    Arthritis Rheumatol; 2016 Feb; 68(2):312-22. PubMed ID: 26473401
    [No Abstract]   [Full Text] [Related]  

  • 7. The enthesis organ concept and its relevance to the spondyloarthropathies.
    Benjamin M; McGonagle D
    Adv Exp Med Biol; 2009; 649():57-70. PubMed ID: 19731620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 and interleukin 23 in the pathogenesis of psoriatic arthritis and spondyloarthritis.
    Cauli A; Mathieu A
    J Rheumatol Suppl; 2012 Jul; 89():15-8. PubMed ID: 22751583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental immunity to the G1 domain of the proteoglycan versican induces spondylitis and sacroiliitis, of a kind seen in human spondylarthropathies.
    Shi S; Ciurli C; Cartman A; Pidoux I; Poole AR; Zhang Y
    Arthritis Rheum; 2003 Oct; 48(10):2903-15. PubMed ID: 14558097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.
    Fantini MC; Pallone F; Monteleone G
    World J Gastroenterol; 2009 May; 15(20):2472-8. PubMed ID: 19468997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity.
    Toussirot E; Saas P; Deschamps M; Pouthier F; Perrot L; Perruche S; Chabod J; Tiberghien P; Wendling D
    Arthritis Res Ther; 2009; 11(4):R101. PubMed ID: 19570209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell studies in the spondyloarthropathies.
    Märker-Hermann E; Schwab P
    Curr Rheumatol Rep; 2000 Aug; 2(4):297-305. PubMed ID: 11123074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "enthesis organ" concept: why enthesopathies may not present as focal insertional disorders.
    Benjamin M; Moriggl B; Brenner E; Emery P; McGonagle D; Redman S
    Arthritis Rheum; 2004 Oct; 50(10):3306-13. PubMed ID: 15476254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spondyloarthropathy: disease at the crossroads of immunity.
    FitzGerald O; McInnes I
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):949-67. PubMed ID: 16980217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of IL-12/23 in T cell-related chronic inflammation: implications of immunodeficiency and therapeutic blockade.
    Schurich A; Raine C; Morris V; Ciurtin C
    Rheumatology (Oxford); 2018 Feb; 57(2):246-254. PubMed ID: 28541488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.
    Raychaudhuri SK; Saxena A; Raychaudhuri SP
    Clin Rheumatol; 2015 Jun; 34(6):1019-23. PubMed ID: 25939522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [General concepts and pathogenesis of the spondyloarthropathies].
    Nissen MJ
    Rev Med Suisse; 2016 Mar; 12(509):485-9. PubMed ID: 27089636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralisation of IL12 p40 or IL23 p40 does not block inflammation in multiple sclerosis.
    Martin R
    Lancet Neurol; 2008 Sep; 7(9):765-6. PubMed ID: 18702995
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy.
    Chaurasia S; Shasany AK; Aggarwal A; Misra R
    Clin Exp Immunol; 2016 Aug; 185(2):210-8. PubMed ID: 27060348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.
    Hacquard-Bouder C; Falgarone G; Bosquet A; Smaoui F; Monnet D; Ittah M; Breban M
    Arthritis Rheum; 2004 May; 50(5):1624-35. PubMed ID: 15146433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.